Why We Would Consider Buying More Eli Lilly Stock If It Were Down
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Eli Lilly and company
Medicare Drug Price Negotiations: Judge Dismisses PhRMA Lawsuit
Activists protest prescription drug pricing in front of the U.S. Department of Health and Human Services (HHS) building on October…
Novo Nordisk and Eli Lilly address supply issues
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
Wall Street gives Eli Lilly and GE Healthcare well-deserved price target hikes
Wall Street liked what it saw from GE Healthcare and Eli Lilly in their earnings reports, leading to a round…
GE Healthcare (GEHC) Stock Finally Gets Some Respect After Q4 Earnings
Business at GE Healthcare Technologies closed 2023 on a strong note despite continued concerns about China. That, along with management's…
Eli Lilly's Weight Loss Drug May Treat Fatty Liver Disease
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
Why Wall Street Analysts Think Big Tech Stocks Will Take a Breath
Every weekday, the CNBC Investing Club with Jim Cramer hosts a livestream of the “morning meeting” at 10:20 a.m. ET.…
Eli Lilly (LLY) Q4 2023 Earnings
The Eli Lilly logo is displayed at one of the company's offices in San Diego, California, U.S., on September 17,…
Novo Nordisk's parent company will buy Catalent to expand Wegovy supply
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
Novo Nordisk Reaches $500 Billion in Market Value as It Points to Growing Demand for Wegovy and Ozempic
Liselotte Sabroe | afp | fake images Novo Nordisk on Wednesday reported better-than-expected profits for 2023 as sales of its…